Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.13
-0.62 (-2.08%)
Feb 21, 2025, 4:00 PM EST - Market closed
Collegium Pharmaceutical Market Cap
Collegium Pharmaceutical has a market cap or net worth of $939.45 million as of February 21, 2025. Its market cap has decreased by -13.33% in one year.
Market Cap
939.45M
Enterprise Value
1.81B
1-Year Change
-13.33%
Ranking
Category
Stock Price
$29.13
Market Cap Chart
Since May 7, 2015, Collegium Pharmaceutical's market cap has increased from $242.20M to $939.45M, an increase of 287.88%. That is a compound annual growth rate of 14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 939.40M | 1.67% |
| Dec 31, 2024 | 924.00M | -7.95% |
| Dec 29, 2023 | 1.00B | 28.87% |
| Dec 30, 2022 | 778.90M | 20.63% |
| Dec 31, 2021 | 645.70M | -6.79% |
| Dec 31, 2020 | 692.70M | 0.39% |
| Dec 31, 2019 | 690.00M | 20.86% |
| Dec 31, 2018 | 570.90M | -5.02% |
| Dec 29, 2017 | 601.10M | 34.93% |
| Dec 30, 2016 | 445.50M | -21.69% |
| Dec 31, 2015 | 568.90M | 134.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |